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When the World Health Organization declared small-pox eradicated in 1979, smallpox vaccination was 
discontinued worldwide. Although cessation of smallpox 
vaccination is well justifi ed, given the risks associated with 
complications from the vaccine, lack of vaccination never-
theless creates a growing population of persons now sus-
ceptible to infection by a few poxviruses previously covered 
by the smallpox vaccine. These include the orthopoxvirus-
es monkeypox; cowpox; and, ironically, vaccinia, the virus 
used for smallpox vaccination. Although few persons die 
from these infections, they are nevertheless a public health 
nuisance and expense. Thus, understanding the epidemiol-
ogy of these viruses is in the interest of public health.
The most common vaccine-preventable poxvirus in-
fections in humans are cowpox and monkeypox (1). Both 
are zoonoses; the natural host for each seems to be rodents, 
and transmission occurs through close contact. Monkeypox 
virus occurs in western and central Africa, causes a dis-
seminated infection in humans, can be transmitted among 
humans at a low rate, and is associated with a 1%–10% 
(depending on the virus strain) case-fatality rate. Cowpox 
virus is relatively common in Europe and Asia, causes a 
limited exanthema, and does not often cause death of previ-
ously healthy persons.
Vaccinia, the virus used in the live smallpox vaccine, 
was originally isolated in the late 18th century from per-
sons with illness that clinically resembled cowpox. How-
ever, modern genomics have shown that the vaccinia virus 
strains used for smallpox control in the 20th and 21st centu-
ries are genetically distinct from cowpox viruses currently 
circulating. In fact, with 2 notable exceptions, vaccinia vi-
rus is not found in nature. However, vaccinia infection has 
been documented in India and Brazil (2). In India, some 
strains of buffalopox, transmitted to humans through buffa-
loes, appear to be vaccinia. Likewise, in Brazil, reports of a 
cowpox-like disease, caused by a vaccinia virus and trans-
mitted from cattle to humans, have increased substantially 
since the fi rst report in 2000. In both outbreaks (India and 
Brazil), evidence suggests that the original source of the vi-
rus was the smallpox vaccine virus that has been introduced 
into the wild—or feral vaccinia, as it has sometimes been 
called. The reservoirs for these viruses in the wild are not 
well understood.
In this issue of Emerging Infectious Diseases, Abrahão 
et al. (3) describe a serosurvey for orthopoxvirus among 
344 wild animals from the Brazilian Amazonia ecosystem. 
The animals, 296 monkeys and a variety of other mammals, 
were captured by a fauna-rescue program during the con-
struction of a hydroelectric plant in Tocantins State, Brazil, 
far removed from other human activity. Of these animals, 
84 (24%), predominantly monkeys, were seropositive for 
orthopoxvirus. Furthermore, 18 serum samples were posi-
tive for orthopoxvirus DNA according to PCR. From these 
18 positive samples, sequencing of 6 isolates revealed the 
vaccinia strain commonly associated with vaccinia out-
breaks among cattle and humans in Brazil. 
These fi nding suggest a remarkably high incidence 
of vaccinia infection in the Brazilian wilderness and in a 
host, namely monkeys, not normally considered as an ac-
tive reservoir for orthopoxviruses. Although Abrahão et al. 
do not specifi cally identify monkeys as a primary reservoir 
for vaccinia virus and do not address the mode of transmis-
sion of the virus among these animals, the results suggest a 
substantial repository of vaccinia virus in the Brazilian wil-
derness. Especially given the broad host range of vaccinia, 
these fi ndings warrant a substantial effort to characterize 
further the circulation of vaccinia virus in this region. If the 
results described in the article by Abrahão et al. (3) can be 
confi rmed and expanded by other laboratories, they would 
have major implications for public health.
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